Johnson David Michael — SEC Form 4 filings
SEC reporting owner CIK 1808098. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-21 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 20,000 shares, $98,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 20,000 shares @ $4.90 ($98,000) in Aura Biosciences, Inc., filed 2025-05-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | Director | 4 | 1 leg · 20,000 sh · $98,000 | — | 7 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | 3 | — | — | 3 |
Form 4 filings — Johnson David Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/award (A): 57,100 @ $0 | EDGAR |
| 2026-06-15 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 13,000 @ $0 · Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/award (A): 57,603 @ $0 | EDGAR |
| 2025-05-20 | 4 | Aura Biosciences, Inc. (AURA) | Purchase (P): 20,000 @ $4.90 · Purchase (P): 5,000 (derivative) | EDGAR |
| 2024-06-24 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 14,500 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/award (A): 48,429 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1808098 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →